Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Nausea 1

Interventions

Dexamethasone 38Aprepitant 31Ondansetron 27Palonosetron 25Granisetron 16Calcium Dobesilate 15Olanzapine 12Therapeutics 8dexamethasone acetate 7Cyclophosphamide 7fosaprepitant 6casopitant 6Doxorubicin 6Radiotherapy 5netupitant 4dolasetron 4dexamethasone 21-phosphate 4Vincristine 4Tropisetron 4Metoclopramide 4Acupressure 4Yoga 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3Electroacupuncture 3Dronabinol 3Cisplatin 3Analgesia 3peppermint oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nausea × lerisetron × Clear all
NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
Genitourinary

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡